Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection

Journal of Biological Chemistry

Volumn 287, Issue 13, 2012, Pages 9940-9951

  Brown, Eric L ^a   Nishiyama, Yasuhiro ^b   Dunkle, Jesse W ^a   Aggarwal, Shreya ^b   Planque, Stephanie ^b   Watanabe, Kenji ^b   Csencsits Smith, Keri ^b   Bowden, M Gabriela ^b,d   Kaplan, Sheldon L ^c   Paul, Sudhir ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF HOUSTON DOWNTOWN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTES; BINDING ACTIVITIES; BINDING DOMAIN; CATALYTIC ANTIBODIES; CATALYTIC MECHANISMS; CATALYTIC RESPONSE; EXTRACELLULAR; HEALTHY HUMANS; PEPTIDE BONDS; RED BLOOD CELL; S. AUREUS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

AMINO ACIDS; BACTERIA; CATALYST ACTIVITY; HYDROLYSIS; MAMMALS; QUANTUM CHEMISTRY;

ANTIBODIES;

BINDING PROTEIN; CATALYTIC ANTIBODY; COMPLEMENT COMPONENT C3B; FIBRINOGEN BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; SUPERANTIGEN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; BACTERIAL VIRULENCE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CHILD; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CYTOLYSIS; FEMALE; HUMAN; MALE; MOUSE; NONHUMAN; NUCLEOPHILICITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; PROTEIN LOCALIZATION; REDUCTION KINETICS; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADAPTIVE IMMUNITY; ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, CATALYTIC; BACTERIAL PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); MUS; STAPHYLOCOCCUS AUREUS;

EID: 84858953619     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.330043     Document Type: Article

References (75)

1. Paul, S., Volle, D. J., Beach, C. M., Johnson, D. R., Powell, M. J., and Massey, R. J. (1989) Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science 244, 1158-1162 (Pubitemid 19170484)
2. Ponomarenko, N. A., Durova, O. M., Vorobiev, I. I., Belogurov, A. A., Jr., Kurkova, I. N., Petrenko, A. G., Telegin, G. B., Suchkov, S. V., Kiselev, S. L., Lagarkova, M. A., Govorun, V. M., Serebryakova, M. V., Avalle, B., Tornatore, P., Karavanov, A., Morse, H. C., 3rd, Thomas, D., Friboulet, A., and Gabibov, A. G. (2006) Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc. Natl. Acad. Sci. U.S.A. 103, 281-286 (Pubitemid 43122392)
3. Paul, S., Planque, S., and Nishiyama, Y. (2010) Immunological origin and functional properties of catalytic autoantibodies to amyloid β peptide. J. Clin. Immunol. 30, Suppl. 1, S43-49
4. Wootla, B., Christophe, O. D., Mahendra, A., Dimitrov, J. D., Repessé, Y., Ollivier, V., Friboulet, A., Borel-Derlon, A., Levesque, H., Borg, J. Y., Andre, S., Bayry, J., Calvez, T., Kaveri, S. V., and Lacroix-Desmazes, S. (2011) Proteolytic antibodies activate factor IX in patients with acquired hemophilia. Blood 117, 2257-2264
5. Berisha, H. I., Bratut, M., Bangale, Y., Colasurdo, G., Paul, S., and Said, S. I. (2002) New evidence for transmitter role of VIP in the airways. Impaired relaxation by a catalytic antibody. Pulm. Pharmacol. Ther. 15, 121-127 (Pubitemid 34762149)
6. Lacroix-Desmazes, S., Wootla, B., Dasgupta, S., Delignat, S., Bayry, J., Reinbolt, J., Hoebeke, J., Saenko, E., Kazatchkine, M. D., Friboulet, A., Christophe, O., Nagaraja, V., and Kaveri, S. V. (2006) Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII. J. Immunol. 177, 1355-1363 (Pubitemid 44036643)
7. Taguchi, H., Planque, S., Nishiyama, Y., Symersky, J., Boivin, S., Szabo, P., Friedland, R. P., Ramsland, P. A., Edmundson, A. B., Weksler, M. E., and Paul, S. (2008) Autoantibody-catalyzed hydrolysis of amyloid β peptide. J. Biol. Chem. 283, 4714-4722
8. Kalaga, R., Li, L., O'Dell, J. R., and Paul, S. (1995) Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. J. Immunol. 155, 2695-2702
9. Gololobov, G., Sun, M., and Paul, S. (1999) Innate antibody catalysis. Mol. Immunol. 36, 1215-1222 (Pubitemid 30137202)
10. Lacroix-Desmazes, S., Bayry, J., Kaveri, S. V., Hayon-Sonsino, D., Thorenoor, N., Charpentier, J., Luyt, C. E., Mira, J. P., Nagaraja, V., Kazatchkine, M. D., Dhainaut, J. F., and Mallet, V. O. (2005) High levels of catalytic antibodies correlate with favorable outcome in sepsis. Proc. Natl. Acad. Sci. U.S.A. 102, 4109-4113 (Pubitemid 40388563)
11. Paul, S. (2011) Two-faced catalytic autoantibodies. Blood 117, 2084-2086
12. Silverman, G. J., and Goodyear, C. S. (2006) Confounding B-cell defences. Lessons from a staphylococcal superantigen. Nat. Rev. Immunol. 6, 465-475
13. Paul, S., Karle, S., Planque, S., Taguchi, H., Salas, M., Nishiyama, Y., Handy, B., Hunter, R., Edmundson, A., and Hanson, C. (2004) Naturally occurring proteolytic antibodies. Selective immunoglobulin M-catalyzed hydrolysis of HIV gp120. J. Biol. Chem. 279, 39611-39619 (Pubitemid 39258228)
14. Planque, S., Mitsuda, Y., Taguchi, H., Salas, M., Morris, M. K., Nishiyama, Y., Kyle, R., Okhuysen, P., Escobar, M., Hunter, R., Sheppard, H. W., Hanson, C., and Paul, S. (2007) Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infection. AIDS Res. Hum. Retroviruses 23, 1541-1554
15. Planque, S., Salas, M., Mitsuda, Y., Sienczyk, M., Escobar, M. A., Mooney, J. P., Morris, M. K., Nishiyama, Y., Ghosh, D., Kumar, A., Gao, F., Hanson, C. V., and Paul, S. (2010) Neutralization of genetically diverse HIV-1 strains by IgA antibodies to the gp120-CD4-binding site from long-term survivors of HIV infection. AIDS 24, 875-884
16. Kluytmans, J., van Belkum, A., and Verbrugh, H. (1997) Nasal carriage of Staphylococcus aureus. Epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10, 505-520 (Pubitemid 27359263)
17. Wertheim, H. F., Melles, D. C., Vos, M. C., van Leeuwen, W., van Belkum, A., Verbrugh, H. A., and Nouwen, J. L. (2005) The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 5, 751-762 (Pubitemid 41688980)
18. DeLeo, F. R., and Chambers, H. F. (2009) Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J. Clin. Invest. 119, 2464-2474
19. Boden, M. K., and Flock, J. I. (1989) Fibrinogen-binding protein/clumping factor from Staphylococcus aureus. Infect. Immun. 57, 2358-2363 (Pubitemid 19183843)
20. Palma, M., Nozohoor, S., Schennings, T., Heimdahl, A., and Flock, J. I. (1996) Lack of the extracellular 19-kDa fibrinogen-binding protein from Staphylococcus aureus decreases virulence in experimental wound infection. Infect. Immun. 64, 5284-5289 (Pubitemid 26403993)
21. Shannon, O., and Flock, J. I. (2004) Extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus binds to platelets and inhibits platelet aggregation. Thromb. Haemost. 91, 779-789 (Pubitemid 38477459)
22. Lee, L. Y., Höök, M., Haviland, D., Wetsel, R. A., Yonter, E. O., Syribeys, P., Vernachio, J., and Brown, E. L. (2004) Inhibition of complement activation by a secreted Staphylococcus aureus protein. J. Infect. Dis. 190, 571-579 (Pubitemid 38982098)
23. Brown, E. L., Bowden, M. G., Bryson, R. S., Hulten, K. G., Bordt, A. S., Forbes, A., and Kaplan, S. L. (2009) Pediatric antibody response to community- acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin. Clin. Vaccine Immunol. 16, 139-141
24. Brown, E. L., Dumitrescu, O., Thomas, D., Badiou, C., Koers, E. M., Choudhury, P., Vazquez, V., Etienne, J., Lina, G., Vandenesch, F., and Bowden, M. G. (2009) The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin. Microbiol. Infect. 15, 156-164
25. Planque, S., Taguchi, H., Burr, G., Bhatia, G., Karle, S., Zhou, Y. X., Nishiyama, Y., and Paul, S. (2003) Broadly distributed chemical reactivity of natural antibodies expressed in coordination with specific antigen binding activity. J. Biol. Chem. 278, 20436-20443 (Pubitemid 36799246)
26. Paul, S., Tramontano, A., Gololobov, G., Zhou, Y. X., Taguchi, H., Karle, S., Nishiyama, Y., Planque, S., and George, S. (2001) Phosphonate ester probes for proteolytic antibodies. J. Biol. Chem. 276, 28314-28320
27. Paul, S., Planque, S., Zhou, Y. X., Taguchi, H., Bhatia, G., Karle, S., Hanson, C., and Nishiyama, Y. (2003) Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120. J. Biol. Chem. 278,20429-20435 (Pubitemid 36799245)
28. Brown, P. M., Debanne, M. T., Grothe, S., Bergsma, D., Caron, M., Kay, C., and O'Connor-McCourt, M. D. (1994) The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization, and a binding-domain mutant. Eur. J. Biochem. 225, 223-233 (Pubitemid 24306247)
29. Pratt, K. P., Shen, B. W., Takeshima, K., Davie, E. W., Fujikawa, K., and Stoddard, B. L. (1999) Structure of the C2 domain of human factor VIII at 1.5-Å resolution. Nature 402, 439-442 (Pubitemid 129544835)
30. Thiagarajan, P., Dannenbring, R., Matsuura, K., Tramontano, A., Gololobov, G., and Paul, S. (2000) Monoclonal antibody light chain with prothrombinase activity. Biochemistry 39, 6459-6465 (Pubitemid 30347151)
31. Lee, L. Y., Liang, X., Höök, M., and Brown, E. L. (2004) Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen-binding protein (Efb). J. Biol. Chem. 279, 50710-50716 (Pubitemid 40017808)
32. Marcatili, P., Rosi, A., and Tramontano, A. (2008) PIGS. Automatic prediction of antibody structures. Bioinformatics 24, 1953-1954
33. Sircar, A., Kim, E. T., and Gray, J. J. (2009) RosettaAntibody. Antibody variable region homology modeling server. Nucleic Acids Res. 37, W474-479
34. Nishiyama, Y., Mitsuda, Y., Taguchi, H., Planque, S., Hara, M., Karle, S., Hanson, C. V., Uda, T., and Paul, S. (2005) Broadly distributed nucleophilic reactivity of proteins coordinated with specific ligand binding activity. J. Mol. Recognit. 18, 295-306 (Pubitemid 41059726)
35. Taguchi, H., Planque, S., Sapparapu, G., Boivin, S., Hara, M., Nishiyama, Y., and Paul, S. (2008) Exceptional amyloid β peptide hydrolyzing activity of nonphysiological immunoglobulin variable domain scaffolds. J. Biol. Chem. 283, 36724-36733
36. Markham, N. P., and Markham, J. G. (1966) Staphylococci in man and animals. Distribution and characteristics of strains. J. Comp. Pathol. 76, 49-56
37. Kiser, K. B., Cantey-Kiser, J. M., and Lee, J. C. (1999) Development and characterization of a Staphylococcus aureus nasal colonization model in mice. Infect. Immun. 67, 5001-5006 (Pubitemid 29455266)
38. Paul, S., Li, L., Kalaga, R., O'Dell, J., Dannenbring, R. E., Jr., Swindells, S., Hinrichs, S., Caturegli, P., and Rose, N. R. (1997) Characterization of thyroglobulin- directed and polyreactive catalytic antibodies in autoimmune disease. J. Immunol. 159, 1530-1536 (Pubitemid 127484134)
39. Mathews, C. K., Holde, K. E. V., and Ahern, K. G. (1999) in Biochemistry, pp. 360-482, Prentice Hall, Upper Saddle River, NJ
40. Hifumi, E., Higashi, K., and Uda, T. (2010) Catalytic digestion of human tumor necrosis factor-α by antibody heavy chain. FEBS J. 277, 3823-3832
41. Yang, Y. H., Chang, C. J., Chuang, Y. H., Hsu, H. Y., Chen, P. P., and Chiang, B. L. (2010) Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity. Rheumatology 49, 34-42
42. Bangale, Y., Karle, S., Planque, S., Zhou, Y. X., Taguchi, H., Nishiyama, Y., Li, L., Kalaga, R., and Paul, S. (2003) VIPase autoantibodies in Fas-defective mice and patients with autoimmune disease. FASEB J. 17, 628-635 (Pubitemid 37221147)
43. Karle, S., Planque, S., Nishiyama, Y., Taguchi, H., Zhou, Y. X., Salas, M., Lake, D., Thiagarajan, P., Arnett, F., Hanson, C. V., and Paul, S. (2004) Cross-clade HIV-1 neutralization by an antibody fragment from a lupus phage display library. AIDS 18, 329-331 (Pubitemid 38253459)
44. Gao, Q. S., Sun, M., Rees, A. R., and Paul, S. (1995) Site-directed mutagenesis of proteolytic antibody light chain. J. Mol. Biol. 253, 658-664
45. Ramsland, P. A., Terzyan, S. S., Cloud, G., Bourne, C. R., Farrugia, W., Tribbick, G., Geysen, H. M., Moomaw, C. R., Slaughter, C. A., and Edmundson, A. B. (2006) Crystal structure of a glycosylated Fab from an IgM cryoglobulin with properties of a natural proteolytic antibody. Biochem. J. 395, 473-481
46. Oleksyszyn, J., Boduszek, B., Kam, C. M., and Powers, J. C. (1994) Novel amidine-containing peptidyl phosphonates as irreversible inhibitors for blood coagulation and related serine proteases. J. Med. Chem. 37, 226-231 (Pubitemid 24063040)
47. Nishiyama, Y., Taguchi, H., Luo, J. Q., Zhou, Y. X., Burr, G., Karle, S., and Paul, S. (2002) Covalent reactivity of phosphonate monophenyl esters with serine proteinases. An overlooked feature of presumed transition state analogs. Arch. Biochem. Biophys. 402, 281-288 (Pubitemid 34848648)
48. Beynon, R. J., and Salvesen, G. S. (2001) in Proteolytic Enzymes: A Practical Approach (Beynon, R. J., and Bond, J. S., eds) Second Ed., pp. 317-330, Oxford University Press, Oxford
49. Dodson, G., and Wlodawer, A. (1998) Catalytic triads and their relatives. Trends Biochem. Sci. 23, 347-352 (Pubitemid 28461867)
50. Pan, B., Maciejewski, M. W., Marintchev, A., and Mullen, G. P. (2001) Solution structure of the catalytic domain of γδ resolvase. Implications for the mechanism of catalysis. J. Mol. Biol. 310, 1089-1107 (Pubitemid 32738380)
51. Wlodawer, A., Li, M., Gustchina, A., Tsuruoka, N., Ashida, M., Minakata, H., Oyama, H., Oda, K., Nishino, T., and Nakayama, T. (2004) Crystallographic and biochemical investigations of kumamolisin-As, a serine-carboxyl peptidase with collagenase activity. J. Biol. Chem. 279, 21500-21510 (Pubitemid 38656560)
52. Karray, S., Juompan, L., Maroun, R. C., Isenberg, D., Silverman, G. J., and Zouali, M. (1998) Structural basis of the gp120 superantigen-binding site on human immunoglobulins. J. Immunol. 161, 6681-6688 (Pubitemid 28562210)
53. Graille, M., Stura, E. A., Corper, A. L., Sutton, B. J., Taussig, M. J., Charbonnier, J. B., and Silverman, G. J. (2000) Crystal structure of a Staphylococcus aureus Protein A domain complexed with the Fab fragment of a human IgM antibody. Structural basis for recognition of B-cell receptors and superantigen activity. Proc. Natl. Acad. Sci. U.S.A. 97, 5399-5404 (Pubitemid 30313730)
54. Bose, B., and Sinha, S. (2005) Problems in using statistical analysis of replacement and silent mutations in antibody genes for determining antigen-driven affinity selection. Immunology 116, 172-183 (Pubitemid 41368659)
55. Chang, B., and Casali, P. (1994) The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol. Today 15, 367-373
56. Hammel, M., Sfyroera, G., Ricklin, D., Magotti, P., Lambris, J. D., and Geisbrecht, B. V. (2007) A structural basis for complement inhibition by Staphylococcus aureus. Nat. Immunol. 8, 430-437 (Pubitemid 46745418)
57. Chen, H., Schuster, M. C., Sfyroera, G., Geisbrecht, B. V., and Lambris, J. D. (2008) Solution insights into the structure of the Efb/C3 complement inhibitory complex as revealed by lysine acetylation and mass spectrometry. J. Am. Soc. Mass Spectrom. 19, 55-65
58. Paul, S., Nishiyama, Y., Planque, S., and Taguchi, H. (2006) Theory of proteolytic antibody occurrence. Immunol. Lett. 103, 8-16 (Pubitemid 43162940)
59. Polosukhina, D. I., Kanyshkova, T. G., Doronin, B. M., Tyshkevich, O. B., Buneva, V. N., Boiko, A. N., Gusev, E. I., Favorova, O. O., and Nevinsky, G. A. (2004) Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis. J. Cell Mol. Med. 8, 359-368 (Pubitemid 44145499)
60. Sun, N. C., Ho, D. D., Sun, C. R., Liou, R. S., Gordon, W., Fung, M. S., Li, X. L., Ting, R. C., Lee, T. H., and Chang, N. T. (1989) Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120. J. Virol. 63, 3579-3585 (Pubitemid 19205426)
61. Goodyear, C. S., and Silverman, G. J. (2003) Death by a B cell superantigen. In vivo VH-targeted apoptotic supraclonal B cell deletion by a staphylococcal toxin. J. Exp. Med. 197, 1125-1139 (Pubitemid 36570068)
62. Kelker, H. C., Itri, V. R., and Valentine, F. T. (2010) A strategy for eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoprotein. PLoS One 5, e8555
63. Hakoda, M., Kamatani, N., Hayashimoto-Kurumada, S., Silverman, G. J., Yamanaka, H., Terai, C., and Kashiwazaki, S. (1996) Differential binding avidities of human IgM for staphylococcal Protein A derived from specific germ-line VH3 gene usage. J. Immunol. 157, 2976-2981 (Pubitemid 126450055)
64. Morris, C. B., Cheng, E., Thanawastien, A., Cárdenas-Freytag, L., and Clements, J. D. (2000) Effectiveness of intranasal immunization with HIVgp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G). Vaccine 18, 1944-1951 (Pubitemid 30122859)
65. Bielinska, A. U., Janczak, K. W., Landers, J. J., Markovitz, D. M., Montefiori, D. C., and Baker, J. R., Jr. (2008) Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates. AIDS Res. Hum. Retroviruses 24, 271-281 (Pubitemid 351282102)
66. Colque-Navarro, P., Palma, M., Soderquist, B., Flock, J. I., and Mollby, R. (2000) Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen-binding proteins. Clumping factor and an extracellular fibrinogen-binding protein. Clin. Diagn. Lab. Immunol. 7, 14-20 (Pubitemid 30051454)
67. Dryla, A., Prustomersky, S., Gelbmann, D., Hanner, M., Bettinger, E., Kocsis, B., Kustos, T., Henics, T., Meinke, A., and Nagy, E. (2005) Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin. Diagn. Lab. Immunol. 12, 387-398 (Pubitemid 41175334)
68. Bermas, B. L., Petri, M., Berzofsky, J. A., Waisman, A., Shearer, G. M., and Mozes, E. (1994) Binding of glycoprotein 120 and peptides from the HIV-1 envelope by autoantibodies in mice with experimentally induced systemic lupus erythematosus and in patients with the disease. AIDS Res. Hum. Retroviruses 10, 1071-1077 (Pubitemid 24314302)
69. Zhou, Y. X., Karle, S., Taguchi, H., Planque, S., Nishiyama, Y., and Paul, S. (2002) Prospects for immunotherapeutic proteolytic antibodies. J. Immunol. Methods 269, 257-268
70. Nishiyama, Y., Planque, S., Mitsuda, Y., Nitti, G., Taguchi, H., Jin, L., Symersky, J., Boivin, S., Sienczyk, M., Salas, M., Hanson, C. V., and Paul, S. (2009) Toward effective HIV vaccination. Induction of binary epitope reactive antibodies with broad HIV neutralizing activity. J. Biol. Chem. 284, 30627-30642
71. Rooijakkers, S. H., van Kessel, K. P., and van Strijp, J. A. (2005) Staphylococcal innate immune evasion. Trends Microbiol. 13, 596-601 (Pubitemid 41661341)
72. Clarke, S. R., and Foster, S. J. (2006) Surface adhesins of Staphylococcus aureus. Adv. Microb. Physiol. 51, 187-224 (Pubitemid 44436456)
73. Otto, M. (2010) Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu. Rev. Microbiol. 64, 143-162
74. Clarke, S. R., Brummell, K. J., Horsburgh, M. J., McDowell, P. W., Mohamad, S. A., Stapleton, M. R., Acevedo, J., Read, R. C., Day, N. P., Peacock, S. J., Mond, J. J., Kokai-Kun, J. F., and Foster, S. J. (2006) Identification of in vivo expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. J. Infect. Dis. 193, 1098 -1108
75. Planque, S., Bangale, Y., Song, X. T., Karle, S., Taguchi, H., Poindexter, B., Bick, R., Edmundson, A., Nishiyama, Y., and Paul, S. (2004) Ontogeny of proteolytic immunity. IgM serine proteases. J. Biol. Chem. 279, 14024-14032 (Pubitemid 38468937)